Cigna new plan to cover expensive gene therapies including Novartis Zolgensma, Luxturna Medical Dialogues Bureau8 Sept 2019 9:00 AM ISTThe first two gene therapies to be included in Cigna Corp's program are blindness therapy, Luxturna, and the most expensive drug in the world...
Roche touts drugs pipeline, rules out Merger and Acquisition just to boost sales Medical Dialogues Bureau7 Sept 2019 9:15 AM ISTRoche has twice upgraded 2019 sales forecasts, the latest time to mid- to high-single-digit percentage rate growth, as medicines including Ocrevus for...
Gene therapy for rare form of blindness wins US approval Ruby Khatun Khatun21 Dec 2017 10:04 AM ISTWASHINGTON: U.S. health officials on Tuesday approved the nation's first gene therapy for an inherited disease, a treatment that improves the sight of...
Gene therapy becomes reality, but at a price tag of 1 million dollar Ruby Khatun Khatun20 Nov 2017 9:45 AM ISTLONDON: Battle lines are being drawn as the first gene therapy for an inherited condition nears the U.S. market, offering hope for people with a rare...